Radiotherapeutisch Instituut Friesland

What Radiotherapeutisch Instituut Friesland does

Radiotherapeutisch Instituut Friesland (RIF) is a regional radiotherapy center headquartered at Borniastraat 36 in Leeuwarden, Netherlands, providing radiation therapy services to cancer patients across the Friesland province. Its core offering is external-beam radiotherapy, supplemented by an advanced MR-Linac capability that combines magnetic resonance imaging with linear accelerator technology to enable real-time tumor visualization during treatment, supporting more precise dose delivery. The institute operates from a single facility and serves patients referred by general practitioners and hospital specialists in the region.

The business operates under the Dutch healthcare-insurance system, with treatments reimbursed through standard health-insurer coverage rather than direct patient payment; the organization also holds ANBI (Algemeen Nut Beogende Instelling) status, indicating a public-benefit/charitable orientation. Supporting services include the MijnRIF patient portal for digital access to medical information and appointments, patient transport services, psychological and pediatric oncology support, educational materials (patient folders and information films), and active participation in scientific research. Ancillary infrastructure covers a client council (cliëntenraad), works council (ondernemingsraad), and a physical-medical staff (Fysisch Medische Staf).

RIF is a privately structured healthcare institution with no parent company, no disclosed funding rounds, and no equity ownership evidenced in the data. Its go-to-market is entirely referral-based — patients arrive via medical referral rather than direct consumer acquisition — and its operational footprint is regional rather than national or international. The institute depends on healthcare IT integration with Chipsoft for clinical and administrative systems, a dependency highlighted by a publicly disclosed security incident at Chipsoft in April 2026.

Name

Radiotherapeutisch Instituut Friesland

Legal name

Radiotherapeutisch Instituut Friesland

Website

https://radiotherapiefriesland.nl

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

RIF is a regional radiotherapy center in Leeuwarden, Netherlands, providing radiation therapy — including MR-Linac treatment — to cancer patients in Friesland referred by GPs and specialists, funded via Dutch health insurance.

Ownership category

akta.pro rank

Product category

Radiation Oncology / Cancer Treatment Services

NAICS

Diagnostic Imaging Centers (621512)

SIC

Services-Health Services (8000)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industry

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

Keywords

• Radiotherapy services
• Cancer radiation therapy
• MR-Linac treatment
• Oncology care services
• Radiation oncology

Headquarters

HQ city

Leeuwarden

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels1 record

Core offering

RIF is a regional radiotherapy institute that delivers radiation therapy to cancer patients, including external beam radiotherapy and MR-Linac treatment that integrates MRI imaging with linear accelerator technology for precision tumor targeting. The facility is based in Leeuwarden and serves patients in the Friesland region referred by general practitioners and medical specialists.

Product overview

Radiotherapeutisch Instituut Friesland (RIF) is a specialized radiation therapy facility providing comprehensive cancer treatment services in Friesland, Netherlands. The organization operates as a single-facility healthcare provider offering radiotherapy treatments as its core service, supplemented by a patient portal (MijnRIF), educational materials, and advanced treatment options such as MR-Linac technology.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiotherapie (Radiation Therapy Services) Core radiotherapy treatment services for cancer patients in Friesland, including external beam radiation therapy and specialized techniques such as MR-Linac, delivered at the RIF facility in Leeuwarden to referred patients.
• MR-Linac Treatment
• MijnRIF (Patient Portal) Online patient portal providing secure access to personal medical information, appointment schedules, and correspondence with healthcare providers for RIF radiotherapy patients.
• Patiëntenfolders (Patient Information Folders) Educational brochures and information folders covering treatment procedures, preparation instructions, and specific treatment types such as prostate external radiation and MR-Linac treatment, made available to referred patients.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• ChipsoftTechnology or IntegrationChipsoft provides healthcare IT systems used by RIF. There was a security incident reported by RIF related to Chipsoft's systems in April 2026.

Recent moves4 records

Expansion highlights4 records

Others

• Elekta: Swedish manufacturer of the Elekta Unity MR-Linac system used by RIF. Vendor/ecosystem peer representing the underlying technology platform RIF's flagship capability depends on.
• ViewRay: US-based MRIdian MR-Linac manufacturer. Competing vendor to Elekta in the MRI-guided radiotherapy segment; relevant as a technology ecosystem peer shaping RIF's modality landscape.

Direct peers

• Maastro Clinic: Maastricht-based standalone radiotherapy clinic providing regional radiation oncology services in the Netherlands. Most direct structural parallel to RIF — independent hospital, regional catchment, advanced treatment modalities.
• Radiotherapie Centrum West: Dutch regional radiotherapy provider operating multiple sites in the western Netherlands. Comparable independent clinic model with multi-site regional coverage.
• Amsterdam Radiotherapie Instituut (ARIE): Independent radiotherapy clinic in the Amsterdam region. Closely comparable independent regional provider with similar treatment portfolio and referral-based patient acquisition.
• Instituut Verbeeten: Tilburg-based independent radiotherapy institute serving the southern Netherlands. Comparable single-specialty regional provider with similar catchment-area model and advanced linac fleet.

Emerging players

• HollandPTC: Delft-based proton therapy center, a partnership between Erasmus MC, LUMC and TU Delft. Comparable advanced-modality radiotherapy operation in the Netherlands, though proton-focused rather than photon/LINAC.

Broad incumbents

• Erasmus MC Kliniek Radiotherapie: Rotterdam-based academic radiotherapy department associated with HollandPTC. Comparable advanced radiotherapy offering within a larger hospital system.
• Antoni van Leeuwenhoek / NKI: Amsterdam-based comprehensive cancer center with embedded radiotherapy department. Larger academic benchmark for advanced radiotherapy in the Netherlands; overlaps with RIF on complex cases.
• UMC Groningen Radiotherapy: Academic hospital radiotherapy department in the northern Netherlands. Competes with RIF for Friesland referrals and offers alternative academic-grade treatment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/rif-radiotherapeutisch-instituut-friesland-leeuwarden-nl

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Radiotherapeutisch Instituut Friesland